Health & MedicineTop StoryTop StoryLatest News
NHS Weight-Loss Jabs: Who Can Get Them?
Sentiment: NeutralHigh Priority
What Happened?
Weight-loss medications like Mounjaro and Wegovy are available on the NHS, but access varies by region. Recent calls for wider access highlight ongoing disparities.
Key points
- Mounjaro and Wegovy help reduce appetite through hormone pathways.
- Access to Mounjaro is limited to adults with a BMI of at least 35 and one weight-related health condition.
- Lower BMI thresholds apply for certain ethnic groups due to higher health risks.
- Wegovy is prescribed for a maximum of two years under NICE guidelines.
- Local NHS services vary in capacity and availability, affecting access to treatments.
Key insights
- The NHS faces challenges in providing consistent access to weight-loss treatments across England.
- Disparities in access may lead to increased private treatment costs for some individuals.
- Long-term care for obesity is essential to prevent weight regain after treatment.
Why it matters
Understanding access to weight-loss medications is crucial for those struggling with obesity.
Source
Express
